Literatur
Fuchs M et al. J Clin Oncol. 2019;37(31):2835-45
André MPE et al. J Clin Oncol. 2017;35(16):1786-94
Radford J et al. N Engl J Med. 2015;372(17):1598-607
Borchmann P et al. Lancet Oncol. 2021;22(2):223-34
Cutter DJ et al. J Clin Oncol. 2021;39(32):3591-601
Hoeller U et al. Dtsch Arztebl Int. 2021;118(12):205-11
Pepper NB et al. Strahlenther Onkol. 2021;197(1):56-62
Oertel M et al. HemaSphere. 2022;6:42
Oertel M et al. Adv Radiat Oncol. 2022;8(3):101169
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oertel, M., Eich, HT. Kardiovaskuläre Risikoevaluation in der Behandlung des Hodgkin-Lymphoms. InFo Hämatol Onkol 26, 26–27 (2023). https://doi.org/10.1007/s15004-023-9957-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-023-9957-2